SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-142288
Filing Date
2019-05-09
Accepted
2019-05-09 08:09:02
Documents
3
Period of Report
2019-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d744358d8k.htm 8-K 19696
2 EX-99.1 d744358dex991.htm EX-99.1 32924
3 GRAPHIC g744358g38b07.jpg GRAPHIC 7095
  Complete submission text file 0001193125-19-142288.txt   63680
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38541 | Film No.: 19808867
SIC: 2834 Pharmaceutical Preparations